524711
VISTAPH
Start SIP
Invest Now
Start SIP in VISTAPH
Performance
- Low
- ₹7
- High
- ₹7
- 52 Week Low
- ₹7
- 52 Week High
- ₹13
- Open Price₹7
- Previous Close₹7
- Volume7,806
- 50 DMA₹8.08
- 100 DMA₹8.65
- 200 DMA₹9.46
Investment Returns
- Over 1 Month -18.55%
- Over 3 Month -26.03%
- Over 6 Month -36.22%
- Over 1 Year -37.16%
Smart Investing Starts Here Start SIP with Vista Pharmaceuticals for Steady Growth!
Vista Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -5.5
- PEG Ratio
- 0
- Market Cap Cr
- 42
- P/B Ratio
- 0.9
- Average True Range
- 0.71
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0.21
- RSI
- 36.89
- MFI
- 31.25
Vista Pharmaceuticals Financials
Vista Pharmaceuticals Technicals
EMA & SMA
Current Price
₹6.85
-0.43
(-5.91%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹7.65
- 50 Day
- ₹8.08
- 100 Day
- ₹8.65
- 200 Day
- ₹9.46
Resistance and Support
6.99
- R3 7.72
- R2 7.50
- R1 7.21
- S1 6.70
- S2 6.48
- S3 6.19
Vista Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-13 | Quarterly Results | (Revised) |
| 2025-11-13 | Quarterly Results | |
| 2025-08-13 | Quarterly Results | |
| 2025-05-30 | Audited Results | |
| 2025-02-19 | Preferential Issue of shares & Others | Inter-alia, to consider 1. Notice of the EGM for the approval of raising of funds. 2. Other business matters. |
Vista Pharmaceuticals F&O
About Vista Pharmaceuticals
- NSE Symbol
- VISTAPH
- BSE Symbol
- 524711
- Managing Director
- Mr. Murali Meraga
- ISIN
- INE427C01021
Similar Stocks to Vista Pharmaceuticals
Vista Pharmaceuticals FAQs
Vista Pharmaceuticals share price is ₹6 As on 14 February, 2026 | 09:11
The Market Cap of Vista Pharmaceuticals is ₹42.2 Cr As on 14 February, 2026 | 09:11
The P/E ratio of Vista Pharmaceuticals is -5.5 As on 14 February, 2026 | 09:11
The PB ratio of Vista Pharmaceuticals is 0.9 As on 14 February, 2026 | 09:11
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.